Sphera Funds Management »

Cartesian Therapeutics shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $677k 25k 27.01